A detailed history of Bamco Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bamco Inc holds 23,000 shares of VRTX stock, worth $10.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
23,000
Previous 23,000 -0.0%
Holding current value
$10.6 Million
Previous $10.8 Million 0.78%
% of portfolio
0.03%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $1.83 Million - $2.06 Million
6,400 Added 38.55%
23,000 $6.64 Million
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $3.9 Million - $4.86 Million
16,600 New
16,600 $4.68 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $11.3 Million - $13.3 Million
-60,113 Closed
0 $0
Q1 2021

May 19, 2021

SELL
$207.02 - $241.31 $15.8 Million - $18.4 Million
-76,256 Reduced 55.92%
60,113 $12.9 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $11 Million - $14.6 Million
53,018 Added 63.61%
136,369 $32.2 Million
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $877,135 - $1.04 Million
3,431 Added 4.29%
83,351 $22.7 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $291,094 - $381,877
1,291 Added 1.64%
79,920 $23.2 Million
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $1.21 Million - $1.5 Million
6,066 Added 8.36%
78,629 $18.7 Million
Q4 2019

Feb 18, 2020

SELL
$166.71 - $223.91 $920,572 - $1.24 Million
-5,522 Reduced 7.07%
72,563 $15.9 Million
Q3 2019

Nov 14, 2019

SELL
$166.23 - $187.09 $229,064 - $257,810
-1,378 Reduced 1.73%
78,085 $13.2 Million
Q2 2019

Aug 15, 2019

SELL
$164.61 - $190.37 $32,263 - $37,312
-196 Reduced 0.25%
79,463 $14.6 Million
Q1 2019

May 15, 2019

SELL
$163.73 - $194.7 $1.19 Million - $1.41 Million
-7,248 Reduced 8.34%
79,659 $14.7 Million
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $75,195 - $95,143
495 Added 0.57%
86,907 $14.4 Million
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $446,161 - $512,688
2,660 Added 3.18%
86,412 $16.7 Million
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $3.15 Million - $3.67 Million
21,615 Added 34.79%
83,752 $14.2 Million
Q1 2018

May 09, 2018

BUY
$151.6 - $177.13 $2.84 Million - $3.32 Million
18,766 Added 43.27%
62,137 $10.1 Million
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $1.87 Million - $2.11 Million
13,588 Added 45.62%
43,371 $6.5 Million
Q3 2017

Nov 15, 2017

BUY
$148.13 - $162.24 $4.41 Million - $4.83 Million
29,783
29,783 $4.53 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.